Overview

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Study Hypothesis: Safety and Tolerability will differ when treating multiple contiguous 25 cm2 treatment areas, as compared to individual 25 cm2 treatment areas.
Phase:
Phase 1
Details
Lead Sponsor:
Peplin